RT Journal Article
SR Electronic
T1 L-dopa and amantadine for parkinsonism
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 65
OP 67
DO 10.1136/dtb.8.17.65
VO 8
IS 17
YR 1970
UL http://dtb.bmj.com/content/8/17/65.abstract
AB Since we discussed L-dopa last year1 the drug has been marketed as Larodopa (Roche) and Brocadopa (Brocades), many further reports on it have been published,2–6 and the lay press has at times exaggerated both its benefits and its adverse effects. Meanwhile another new drug, amantadine (Symmetrel - Geigy), has also been introduced for Parkinsonism.